Recursion
RXRX
Performance
About Recursion
Recursion is a biotechnology company leveraging AI-driven drug discovery to decode biology and accelerate the development of new medicines. By imaging cells and training machine learning models on phenomics, transcriptomics, and other omics data, they aim to shorten hit identification to IND-enabling studies and improve success rates in areas like oncology and rare diseases. The company operates from Salt Lake City, Utah, and emphasizes its Recursion Operating System and partnerships with pharma and tech leaders to advance faster, cost-efficient drug development.
Recent News
Isomorphic Labs Raises $2.1 B to Expand AI-Driven Drug Discovery Platform
The 5 Largest IPOs in Biopharma History
Zuckerberg, Chan's Biohub Launches Protein 'World Model'
The Company that Built TikTok’s Algorithm Is Now Designing Drugs for Diseases Pharma Called Undruggable
AI Needs a Reality Check
Isomorphic Labs Pulls $2.1B Series B Led By Thrive With MGX, Temasek, And UK Sovereign AI Fund: What The Capital Stack, IsoDDE Engine, And Novartis/Lilly/J&J Partnerships Mean For Drug Discovery
The Stanford Professor Behind an FDA-Cleared Cardiac AI Wants $1 Billion for His Next Company
OpenBind Unveils Its First AI Model for Drug Discovery
Ship Fast, Optimize Later: Top AI Engineers Don't Care About Cost — They're Prioritizing Deployment
Founders Face Pressure From All Sides as Biotech Crawls Toward Recovery
Ovid Takes Another Big Swing in Neuroscience Under a New CEO
Isomorphic Labs Raises $2.1 B Series B to Scale AI Drug‑Design Engine
Isomorphic Labs Secures $2.1 B Series B to Accelerate AI Drug Discovery
What’s Next for AlphaFold: A Conversation with a Google DeepMind Nobel Laureate
Alamar Biosciences Upsizes IPO, Raises $191.3 M to Accelerate Cell‑Based Drug Discovery
Federation Plus Fine Tuning: The Push for Federated Learning Models Continues
Theorem Wants to Stop AI-Written Bugs Before They Ship — and Just Raised $6M to Do It
Goldman Is Betting Nvidia Will Get a Boost From Health Care as Industry Builds Out AI Capabilities
Biotech Has Become a Good News Story. Let the Sun Shine
Takeda, Iambic Partner in Latest Pharma AI Push
Why Recursion Pharmaceuticals Inc (RXRX) Expanded Citeline Partnership
Recent Deals
No recent deals for this company.